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Abstract 
 
Background: 
Low levels of vitamin D are associated with cardiovascular diseases in adults; however, it is unclear 
if there is a relationship between vitamin D in pregnancy and cardiovascular diseases in offspring.  
Aim: 
To assess the association of maternal circulating 25-hydroxyvitamin D (25(OH)D) at 12 weeks of 
pregnancy and child concentrations of (25(OH)D) in preschool age with offspring pulse wave 
velocity, retinal microcirculation and blood pressure at 11 years.  
Methods: 
We included 401 mother-child pairs from the INMA-Sabadell cohort study. We used plasma 
(25(OH)D) at first trimester of pregnancy and offspring plasma at 4 years. Main outcomes 
measured at 11 years were pulse wave velocity, central venular retina equivalent (CRVE), central 
retinal arteriolar equivalent (CRAE), and systolic and diastolic blood pressures. We used 
(25(OH)D) as a continuous and categorical variable: deficiency (≤20 ng/ml), insufficiency (21-30 
ng/ml), and sufficiency (>30 ng/ml).  
Results: 
The median plasma levels of 25(OH)D3 were 29.63 and 37.17 ng/ml in pregnancy and childhood, 
respectively. Higher maternal vitamin D levels were associated with an increase in systolic blood 
pressure [beta = 1.06 (95% CI=0.14, 1.97)] but not with diastolic blood pressure. Maternal vitamin 
D levels were not associated with pulse wave velocity or with microcirculation. Vitamin D in pre-
scholar age was not associated with any of the cardiovascular outcomes assessed. 
Conclusions: 
This study finds little evidence of associations between vitamin D levels during pregnancy or in 
pre-school age with cardiovascular outcomes in children. Further studies will be needed to 
understand more clearly the influence of prenatal and early life vitamin D levels on cardiovascular 
disease in childhood. 
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1. Introduction 
 
Cardiovascular diseases (CVD) are a major public health problem worldwide1. In Europe, 
cardiovascular diseases represent nearly 45% of total mortality (about 4 million deaths) every year2. 
The main risk factors include obesity3,4, abdominal adiposity5,4, lipid disorders6–8, blood pressure 
and hypertension9,8. Lifestyle also plays an important role in CVD risk because people with low 
levels of physical activity10,11 and low consumption of fruits and vegetables12 have an increased 
risk of CVD. 
Low maternal vitamin D levels have been related with poor childhood development including an 
increased risk of being born premature or small for gestational age, being overweight13, having 
more body fat, and higher levels of HDL cholesterol in childhood14. Recent studies have shown 
that low levels of 25-hydroxyvitamin D (25(OH)D) are an important risk factor for CVD in adults 
and elderly people15–17. In children, two studies conducted in Asia showed an association between 
low levels of vitamin D and CVD risk18,19. Other studies in children showed an association between 
low levels of vitamin D (under 20 ng/ml) and higher risk of CVD onset, regardless of physical 
activity and body fat20–22.  
In recent years, it has been a growing interest to measure CVD by using early markers of CVD in 
childhood, including pulse wave velocity23, retinal microcirculation24, and blood pressure25. Pulse 
wave velocity (PWV) is also non-invasive method to detect early arterial stiffness, and it is 
considered an independent cardiovascular risk factor marker26,27. Traditionally PWV has been used 
as a marker of CVD risk in adults and elderly, however, recent studies have proposed this marker 
as an estimate of arterial stiffness also in pediatric populations27,28,29,30. Retinal microcirculation is 
a non-invasive method used in adults to detect of cardiovascular disease early. This marker is 
related to the appearance of coronary artery disease24, because the change in this microcirculation 
is a predictor of ambulatory blood pressure24,31,32.This marker has also been suggested for the 
detection of early cardiovascular dysfunction in pediatric populations32, as shown in recent studies 
that reported an association between arteriolar and venular adaptations in the retina during 
childhood and CVD risk factors later in adult life25. Finally, blood pressure can also be a useful 
early marker of CVD since elevated blood pressure in pediatric population persists over time33 and 
long-term oscillation of blood pressure is associated with CVD risk8. In pediatric populations, the 
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association of low serum vitamin D concentrations with elevated systolic blood pressure in children 
is likely related to others CVD markers34.  
2. Objective 
In this study, we aimed to assess the association of maternal circulating 25-hydroxyvitamin 
D (25(OH)D) at 12 weeks of pregnancy and child concentrations at preschool age with offspring 
pulse wave velocity, retinal microcirculation and blood pressure in 11 age children. 
3. Materials and Methods  
3.1 Study population 
We used data from the INfancia y Medio Ambiente – Environment and Childhood (INMA) 
Project35. The INMA project is a prospective population-based cohort study of mothers and 
children conducted in 7 Spanish regions. In the present study, we used data from the Sabadell 
region. Women were recruited between the 10 and 13 weeks of pregnancy in health care centers 
between July 2004 and July 2006. The inclusion criteria were: a) to be 16 years old or older, b) to 
have a single pregnancy, c) not having followed an assisted reproduction program, d) to wish to 
deliver in the reference hospital, and e) to have no communication problems. Women were assessed 
in the first and third trimesters of pregnancy and their offspring at birth, 14 months, 4, 7, 9 and 11 
years of age. 
In the present analyses, we included 373 woman-child pairs with data on vitamin D during 
pregnancy and at least one cardiovascular measurement at 11 years (mean = 11.14 years [standard 
deviation (SD) = 0 .53]). A flow diagram is shown in Figure 1. All the participants of the study 
read and signed a written informed consent form. The study was approved by the ethics committee 
of the reference hospital in the Sabadell region. 
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Figure 1. Flow chart of study cohort selection. 
 
3.2 Vitamin D assessment  
Maternal vitamin D levels were assessed using plasmatic levels from a single maternal fasting 
blood sample collected in the first trimester of pregnancy (mean = 13.69 [SD = 1.86] weeks of 
gestation). The childrens’ vitamin D was assessed using plasmatic levels from a single blood 
sample collected at 4 years. Quantification of plasma levels of 25(OH)D3 was performed by High 
Performance Liquid Chromatography (HPLC) using a BioRAD kit, according to Clinical and 
Laboratory Standard Institute (NCCLS) protocols, which were validated by the German Program 
of External Evaluation of Quality (DGKL- RFBReferencezinstutuk fur Bionalytik)36. In this study, 
the cut off for vitamin D in pregnancy and child was defined based on the Endocrine Society 
clinical practice guidelines37: deficiency (≤20ng/ml), insufficiency (21-30ng/ml), and sufficiency 
(>30ng/ml). 
 5 
 
3.3 Cardiovascular measurements 
3.3.1 Pulse wave velocity 
 
Cardio-femoral pulse wave velocity was measured in the clinical visit by a VICORDER® - Arterial 
Stiffness Testing System. Measurements were performed in barefoot children in sternal decubitus, 
without heavy clothes. A cushion was placed on the neck and shoulders to provide 30º degree 
inclinations to the heart. Cuffs were placed on the upper right thigh and the neck and connect to 
the Vicorder. The carotid pulse was detected, the cuff placed around the neck and the cuff then 
connected to the Vicorder. The thigh cuff was placed on the upper right thigh as high as possible, 
and the child was requested not to move while measurements were taken. Two measurements were 
conducted, for systolic and diastolic blood pressures, a measures are were given in m/sec and each 
measurement was repeated twice consecutively38–43.  
3.3.2 Retinal Microcirculation  
A non-myriatic approach was applied in a poorly lit room, seeking to obtain photographs of the 
retina, an image per eye in each child, with a Canon Cr-DGi Retinal visualization system combined 
with the Canon D-50 digital camera (Canon INC, Medical Equipment Group, Utsunomiya, Japan). 
Two trained observers applied the validated computer-assisted program IVAN (Vasculomaticala 
Nicola, version 1.1, Department of Ophthalmology and Visual Science, University of Wisconsin-
Madison, Madison, WI, USA)44,45, which returns the average of the arteriolar and venous diameters 
of the retina46. Microvascular diameters of the retina are expressed as central retinal arteriolar 
equivalent (CRAE) and central venular retina equivalent (CRVE), producing measures in μm. For 
analysis, measurements of left and right  eyes were averaged47.  
 
3.3.3 Blood pressure  
Blood pressure was measured with an Omron 705IT (HEM-759-E, Omron Corporation, Kyoto, 
Japan). A suitable cuff was used for each child; the balloon width was 40% of the circumference 
of the arm at an intermediate point between the olecranon and the acromion. The length of the cuff 
bladder was 80% to 100% of the children’s arm circumference. The children were seated, with 
arms and backs supported and feet on the ground. It was preferable that the right arm was exposed 
without clothing, palm facing up, elbow flexible, and the midpoint of the arm was at the level of 
the heart. The use of the right arm was preferred. After 5 minutes of rest, 3 consecutive measures 
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were taken48. We used the average between the 2nd and 3rd measurements (systolic and diastolic). 
This variable was used in two formats, systolic blood pulse and diastolic blood pulse, a measure 
are were given in mmHg.  
3.4 Covariates 
We used the following confounders based on the literature. For maternal exposure analyses: pre-
pregnancy BMI (kg/m2), age at delivery (years), smoking during pregnancy (never smokers; partial 
smokers who quit at the beginning of pregnancy or smoking at some point during pregnancy), 
gestational age (<37 weeks; > 37 weeks), mother educational level (primary or without education; 
secondary or university), parity (none; 1 child; and 2 or more children), season at blood drawn in 
mother (winter; spring; summer or fall), mother ethnicity (caucasian; no caucasian). For child 
exposure analyses: sex (male; female), height at 11 years (centimeter), child age of assessment 
(years), BMI Child- 4 years. 
 
3.5 Statistical analysis 
We tested all variables of interest for normality using graph and Shapiro–Wilk test. We examined 
mean, SD or percentages and missing in socio-demographic characteristic of all participants 
(included and excluded from the study). We also explored mean, SD or percentages of socio-
demographic and anthropometric characteristic across the three categories of maternal vitamin D. 
We assessed differences using ANOVA for continuous variables and X2 for categorical variables. 
We assessed the distribution of the outcomes (PWV, CRAE, CRVE, and systolic and diastolic 
blood pressure) according to maternal vitamin D categories and used ANOVA or X² to explore 
differences between groups. We used the exposure variables (maternal and child vitamin D levels) 
as continuous (increase in 10 ng/ml) and categorical (deficiency (≤20ng/ml) – reference, 
insufficiency (21-30ng/ml), and sufficiency (>30ng/ml)). To assess the association between 
concentrations of vitamin D (continuous and categorical) and the outcomes, we used multivariate 
linear regression models with 4 levels of adjustment. For maternal vitamin D models: (a) Model 1, 
which was minimally adjusted for sex and age of the child at the time of outcome assessment; (b) 
Model 2, which was model 1 further adjusted for the season when blood was drawn, maternal age, 
maternal education, parity, smoking during pregnancy and maternal ethnicity; c) Model 3, which 
was model 2 further adjusted for maternal body mass index and d) Model 4, which was model 3 
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further adjusted for height of the child at 11 years. Child vitamin D models were the following: a) 
Model 1, which was minimally adjusted for sex and age of the child at the time of outcome 
assessment; b) Model 2, which was model 1 further adjusted for the season when blood was drawn, 
maternal education, and physical activity of the child at 4 years; (c) Model 3, which was model 2 
further adjusted for body mass index of the child at 4 years; and (d) Model 4, which was model 3 
further adjusted for height of the child at 11 years. All statistical analyses were conducted with 
STATA 14.2. The threshold for significance was set at 0.05. 
 
4. Results 
 
Study population characteristics 
Mothers included in the study were older (mean 31.98 SD 4.12), less likely to smoke during 
pregnancy (73.33%), higher educated (75.79%), were more likely to be nulliparous (57.37%), 
Caucasian (98.43%), and had a term delivery (98.17%) than mothers not included in the study 
(Table 1).  
  
Table 1. Table maternal and child group characteristics of included and excluded populations 
Variables Included Excluded   
 N=373 (58%) N=269 (42%)   
 
Mean 
or N  
 SD or 
% Mean or N  
 SD or 
%  p Missing  
Maternal characteristics        
Vitamin D levels in pregnancy (ng/ml) 29.63 11.54 28.57 11.62 0.256 2.28% 
Pre-pregnancy BMI (kg/m2) 23.71 4.47 23.69 4.45 0.968 0.15% 
Age at delivery (years) 31.98 4.12 30.69 4.66 <0.01 5.78% 
Smoking during pregnancy (N, %) 
    
0.039 7.15% 
   Never 275 73.33 152 64.68   
   Partial smokers  53 14.13 37 15.74   
   Smoking at some point during pregnancy  47 12.53 46 19.57   
Educational level (N, %)     <0.01 0.61% 
   Primary or without education 92 24.21 97 35.53   
   Secondary 161 42.37 118 43.22   
   University 127 33.42 58 21.25   
Parity (N, %) 
 
   0.502 0.61% 
   No children 218 57.37 147 53.85   
   1 child 139 36.58 104 38.10   
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   2 or more children 23 6.05 22 8.06   
Season at blood drawn mother (N, %)     0.890 2.28% 
   Winter  86 23.06 57 21.19   
   Spring  88 23.59 63 23.42   
   Summer 92 24.66 73 27.14   
   Fall 107 28.69 76 28.25   
Ethnicity (N, %)     0.003 0.30% 
   Caucasian 375 98.43 258 94.16%   
   No Caucasian  6 1.57 16 5.84   
Child characteristics        
Vitamin D levels at 4 years (ng/ml) 37.17 15.65 37.83 15.44 0.763 55.56% 
Sex (N, %)     0.310 5.63% 
   Female  183 47.91 124 52.10   
   Male 199 52.09 114 47.90   
Gestational age (N, %)     0.007 5.63% 
    <37 weeks 375 98.17 224 94.12   
    > 37 weeks  7 1.83 14 5.88   
 
The characteristics of the population according to concentrations of maternal vitamin D are shown 
in Table 2. Mothers has less pre-pregnancy BMI are deficiency levels (mean 22.85 SD 3.45), oldest 
women`s has more sufficiency (mean 32.32 SD 4.18), mothers with deficiency smoked more 
(19.54%), most mothers studied secondary education (42.36%), most mothers had no other 
children (56.84%), and most are Caucasian (98.39%). Children were mostly male (51.47%) and 
most were over 37 weeks of gestation (98.12%). Lower education level was more likely to have 
vitamin D deficiency. There were variations in concentration across the seasons when the blood 
was drawn. Offspring of women with a deficiency of vitamin D had lower concentrations of 
vitamin D in school age. 
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Table 2. Table characteristics of the population according to concentrations of maternal vitamin D 
Variables Continuous Categorized  
  
Deficiency        
(≤ 20ng/ml) 
Insufficiency 
(21-30ng/ml) 
Sufficiency 
(>30ng/ml) 
 
 N= 373 (100%) 
N=87 (23.32%) N=93 (24.93%) N=193 (51.74%) 
 
 N % Mean  SD  Mean  SD  Mean  SD  p 
Variables          
Pre-pregnancy BMI (kg/m2) 23.7 4.50 22.86 3.45 24.30 5.45 23.79 4.38 0.092 
Age at delivery (years) 31.96 4.10 31.51 4.08 31.65 3.92 32.32 4.18 0.215 
Smoking (N, %)   
 
     0.053 
   Never 266 71.31 55 63.22 67 75.28 144 75.79  
   Partial smokers  53 14.21 15 17.24 16 17.98 22 11.58  
   Smoking at some point during 
pregnancy  47 12.60 17 19.54 6 6.74 24 12.63  
Educational level (N, %)         0.131 
   Primary or without education 91 24.40 26 30.23 26 27.96 39 20.21  
   Secondary 158 42.36 39 45.35 39 41.94 80 41.45  
   University 123 32.98 21 24.42 28 30.11 74 38.34  
Parity (N, %)         0.606 
0 Children 212 56.84 54 62.79 48 51.61 110 57.29  
1 Children 137 36.73 27 31.40 40 43.01 70 36.46  
2 Children’s  22 5.90 5 5.81 5 5.38 12 6.25  
Season at blood drawn mother  
(N, %)         0.000 
Winter  86 23.06 40 45.98 16 17.20 30 15.54  
 Spring  88 23.59 25 28.74 17 18.28 46 23.83  
Summer 92 24.66 8 9.20 33 35.48 51 26.42  
Fall 107 28.69 14 16.09 27 29.03 66 34.20  
Ethnicity (N, %)         0.048 
Caucasian 367 98.39 87 100.00 89 95.70 191 98.96  
No Caucasian  6 1.61 0 0.00 4 4.30 2 1.04  
Child characteristics           
Vitamin D in offspring (N, %) 223 59.79 62 27.80 58 26.01 103 46.19 0.010 
Sex (N, %)         0.950 
Female  181 48.53 41 47.13 46 49.46 94 48.70  
Male 192 51.47 46 52.87 47 50.54 99 51.30  
Gestational age (N, %)         0.891 
<37 weeks 7 1.88 2 2.30 2 2.15 3 1.55  
> 37 weeks  366 98.12 85 97.70 91 97.85 190 98.45  
Waist circumference 11 years 373 100 87 23.32 93 24.93 193 51.74 0.910 
Height at 11 years 373 100 87 23.32 93 24.93 193 51.74 0.710 
Age of Assessment 373 100 87 23.32 93 24.93 193 51.74 0.029 
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The distribution of the child cardiovascular outcomes according to the categories of maternal 
vitamin D concentration is shown in Table 3. The lowest values of CRVE correlated with vitamin 
D insufficiency (mean 251.76 SD 15.32). The same is true of CRAE (mean 180.79 SD 12.75), 
pulse wave velocity (mean 4.34 SD 0.52), systolic blood pressure (mean 100.81 SD 8.65) and 
diastolic blood pressure (mean 58.66 SD 6.92). There were no significant differences between the 
categories for any of the outcomes of interest. 
 
Table 3. Table description of outcomes according to maternal vitamin D concentrations. 
Variables Continue Categorized 
 
 
  Deficiency     
(≤ 20ng/ml) 
Insufficiency 
(20-30ng/ml) 
Sufficiency 
(>30ng/ml) 
 
 
 N= 373 
(100%) 
N= 87 
(23,23%)  
N=93  
(24.93%) 
N= 193 
(51.74%) 
 
 
 Mean SD Mean  SD  Mean  SD  Mean  SD  p  
CRVE (μm) 252.24 0.88 253.08 16.85 251.76 15.32 251.82 17.96 0.830  
CRAE (μm) 181.14 0.65 181.76 12.81 180.79 12.75 181.33 12.54 0.943  
PWV(m/sec) 4.37 0.02 4.34 0.52 4.35 0.43 4.38 0.44 0.703  
Systolic (mmHg) 101.69 0.50 101.30 10.53 100.81 8.65 102.29 9.81 0.441  
Diastolic (mmHg) 59.81 0.38 60.20 7.11 58.66 6.92 60.37 7.59 0.067  
Abbreviations: Pulse Wave velocity (PWV), Central Retinal Venular Equivalents (CRVE), Central 
Retinal Arteriolar Equivalents (CRAE), blood pressure systolic (Systolic), blood pressure diastolic 
(Diastolic) 
 
Maternal Circulating Vitamin D Concentrations and Cardiovascular Outcomes in the 
Offspring 
 
An association of maternal circulating 25-hydroxyvitamin D concentrations at 12 weeks of 
pregnancy and offspring arterial stiffness and retinal microcirculation was found. For pulse wave 
velocity, values close to zero in continuous and categorical vitamin D were found, but not 
significant to the β (95%CI). Central retinal venular equivalent (CRVE) was found to be negatively 
associated to continuous and categorical vitamin D levels, but not significant to the β (95%CI). 
Central retinal arteriolar equivalent (CRAE) was found to be a value close to zero in continuous 
and categorical vitamin D, but not significant to the β (95% CI). All values are shown in Table 4.  
The results of association between maternal 25-hydroxyvitamin D concentrations at 12 weeks of 
pregnancy and offspring systolic and diastolic blood pressure are shown in Table 5. There was a 
correlation between systolic blood pressure and vitamin D in model 2 (1.06 (0.14 , 1.98) and model 
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3 (1.06 (0.14 , 1.97)), however, when categorised, these results are not clear and not significant to 
β (95% CI).Diastolic blood pressure in continuous vitamin D was found to have values close to 
zero, but not significant to β (95%CI). The insufficiency category (21 – 30ng/ml) was found to 
have a negative correlation in all 4 regression models, but not significant to β (95% CI). 
 
Child Circulating Vitamin D Concentrations at preschool age and Cardiovascular Outcomes 
in childhood 
Association of child circulating 25-hydroxyvitamin D concentrations at 4 years and offspring pulse 
wave velocity in retinal microcirculation was found a values close to zero it was not significant β 
(95%CI), in central retinal venular equivalent (CRVE) was found a negative values in continuous 
and categorical vitamin D, but not significative to β (95%CI). Central retinal arteriolar equivalent 
(CRAE) was found negative values close to zero in continuous vitamin D in categorical category 
the values decrease, but not significative to β (95%CI). All values show in Table 6. 
The results association to child circulating 25-hydroxyvitamin D concentrations at 4 years and 
offspring, demonstrated in table 7. The systolic and diastolic blood pressure, in continuous and 
categorical variables was found negative values and close to zero but not significative to β (95%CI). 
In children at 4 years results show be a no association to vitamin D to cardiovascular markers, pulse 
wave velocity, retinal microcirculation and blood pressure at 11 years.  
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Table 4. Association of maternal circulating 25-hydroxyvitamin D concentrations at 12 weeks of pregnancy and offspring 
arterial stiffness and retinal microcirculation.  
  N Model 1 β (95%CI) Model 2 β (95%CI) Model 3 β (95%CI) Model 4 β (95%CI) 
PWV 
Continuous 10 ng/ml  373 0.02 (-0.19, 0.06) 0.03 (0.00, 0.07) 0.03 (0.00, 0.07) 0.02 (-0.01, 0.06) 
≤20ng/ml  87 Ref Ref Ref Ref 
21 – 30ng/ml  93 0.01 (-0.11, 0.15) 0.00 (-0.13, 0.14) 0.00 (-0.14, 0.13) -0.01 (-0.15, 0.11) 
> 30ng/ml  193 0.06 (-0.05, 0.17) 0.09 (-0.03, 0.21) 0.08 (-0.04, 0.20) 0.05 (-0.06, 0.17) 
CRVE 
Continuous 10 ng/ml 373 -0.40 (-1.92, 1.11) -0.39 (-2.06, 1.27) -0.39 (-2.06, 1.27) -0.29 (-1.96, 1.36) 
≤20ng/ml  87 Ref Ref Ref Ref 
21 – 30ng/ml  93 -1.42 (-6.42, 3.56) -1.74 (-7.22, 3.72) -1.69 (-7.20, 3.82) -1.55 (-7.04, 3.93) 
> 30ng/ml  193 -1.50 (-5.85, 2.85) -1.69 (-6.52, 3.13) -1.66 (-6.51, 3.18) -1.32 (-6.16, 3.51) 
CRAE 
Continuous 10 ng/ml 373 0.00 (-1.11, 1.12) -0.11 (-1.36, 1.12) -0.11 (-1.35, 1.12) -0.07 (-1.31, 1.17) 
≤20ng/ml  87 Ref Ref Ref Ref 
21 – 30ng/ml  93 -0.35 (-4.04, 3.33) 0.11 (-3.97, 4.19) 0.34 (-3.76, 4.44) 0.40 (-3.70, 4.50) 
> 30ng/ml  193 0.22 (-2.98, 3.44) 0.21 (-3.38, 3.81) 0.32 (-3.28, 3.93) 0.47 (-3.13, 4.09) 
Abbreviations: Pulse Wave velocity (PWV), Central Retinal Venular Equivalents (CRVE), Central Retinal Arteriolar Equivalents 
(CRAE). 
Model 1: Adjusted for sex and age of the child at the time of outcomes assessment.   
Model 2: Model 1 further adjusted for the season when blood was drawn, maternal age, maternal education, parity, smoking 
during pregnancy and maternal ethnicity. 
Model 3: Model 2 further adjusted for body mass index at pre pregnancy.   
Model 4: Model 3 further adjusted for height at 11 years.    
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Table 5. Association of maternal circulating 25-hydroxyvitamin D concentrations at 12 weeks of pregnancy and offspring 
systolic and diastolic blood pressure. 
    N Model 1 β (95%CI) Model 2 β (95%CI) Model 3 β (95%CI) Model 4 β (95%CI) 
Systolic  
Continuous 10 ng/ml  373 0.58 (-0.25, 1.44) 1.06 (0.14, 1.98) 1.06 (0.14, 1.97) 0.90 (-0.37, 1.78) 
≤20ng/ml  87 Ref Ref Ref Ref 
21 – 30ng/ml  93 -0.39 (-3.19, 2.40) 0.50 (-2.51, 3.52) -0.15 (-2.86, 3.17) -0.06 (-2.94, 2.80) 
> 30ng/ml  193 1.55 (-0.88, 3.99) 2.82 (-0.15, 5.48) 2.65 (0.00, 5.30) 2.09 (-0.43, 4.62) 
Diastolic 
Continuous 10 ng/ml 373 0.34 (-0.31, 1.00) 0.49 (-0.21, 1.19) 0.48 (-0.21, 1.19) 0.42 (-0.27, 1.11) 
≤20ng/ml  87 Ref Ref Ref Ref 
21 – 30ng/ml  93 -1.88 (-4.03, 0.25) -2.02 (-4.31, 0.27) -2.17 (-4.48, 0.12) -2.27 (-4.54, 0.00) 
> 30ng/ml  193 0.37 (-1.49, 2.24) 0.51 (-1.51, 2.53) 0.43 (-1.58, 2.46) -0.19 (-1.80, 2.20) 
Abbreviations: blood pressure systolic (Systolic), blood pressure diastolic (Diastolic).   
Model 1: Adjusted for sex and age of the child at the time of outcomes assessment. 
  
Model 2: Model 1 further adjusted for the season when blood was drawn, maternal age, maternal education, parity, smoking 
during pregnancy and maternal ethnicity.  
Model 3: Model 2 further adjusted for body mass index at pre pregnancy.     
Model 4: Model 3 further adjusted for height at 11 years.    
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Table 6. Association of child circulating 25-hydroxyvitamin D concentrations at 4 years and offspring arterial stiffness and 
retinal microcirculation. 
    N Model 1 β (95%CI) Model 2 β (95%CI) Model 3 β (95%CI) Model 4 β (95%CI) 
PWV 
Continuous 10 ng/ml  373 0.00 (-0.03, 0.04) 0.00 (-0.03, 0.04) 0.00 (-0.03, 0.03) 0.00 (-0.03, 0.04) 
≤20ng/ml  87 Ref Ref Ref Ref 
21 – 30ng/ml  93 -0.02 (-0.23, 0.17) -0.03 (-0.24, 0.18) -0.02 (-0.23, 0.18) -0.03 (-0.23, 0.17) 
> 30ng/ml  193 0.02 (-0.16, 0.21) 0.03 (-0.16, 0.22) 0.03 (-0.16, 0.22) 0.04 (-0.14, 0.23) 
CRVE 
Continuous 10 ng/ml 373 -0.18 (-1.72, 1.35) -0.33 (-1.90, 1.24) -0.29 (-1.84, 1.24) -0.38 (-1.93, 1.16) 
≤20ng/ml  87 Ref Ref Ref Ref 
21 – 30ng/ml  93 -1.69 (-10.09, 6.70) -1.01 (-9.32, 7.29) -1.06 (-9.38, 7.26) -0.88 (-9.16, 7.38) 
> 30ng/ml  193 -0.61 (-6.94, 8.17) 1.19 (-6.54, 8.93) 1.17 (-6.57, 8.93) 0.92 (-6.78, 8.63) 
CRAE 
Continuous 10 ng/ml 373 -0.68 (-1.77, 0.39) -0.88 (-2.03, 0.26) -0.74 (-1.88, 0.39) -0.73 (-1.88, 0.40) 
≤20ng/ml  87 Ref Ref Ref Ref 
21 – 30ng/ml  93 -4.78 (-10.69, 1.12) -4.73 (-10.81, 1.34) -4.84 (-10.90, 1.22) -4.85 (-10.93, 1.22) 
> 30ng/ml  193 -3.01 (-8.32, 2.29) -3.39 (-9.05, 2.26) -3.43 (-9.08, 2.21) -3.42 (-9.08, 2.24) 
Abbreviations: Pulse Wave velocity (PWV), Central Retinal Venular Equivalents (CRVE), Central Retinal Arteriolar Equivalents 
(CRAE). 
Model 1: Adjusted for sex and age of the child at the time of outcomes assessment.   
Model 2: Model 1 further adjusted for season, maternal education and physical activity of the children at 4 years.  
Model 3: Model 2 further adjusted for body mass index at 4 years.    
Model 4: Model 3 further adjusted for height at 11 years.    
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Table 7. Association of child circulating 25-hydroxyvitamin D concentrations at 4 years and offspring systolic and diastolic 
blood pressure. 
    N Model 1 β (95%CI) Model 2 β (95%CI) Model 3 β (95%CI) Model 4 β (95%CI) 
Systolic  
Continuous 10 ng/ml  373 0.33 (-0.49, 1.16) 0.29 (-0.57, 1.16) 0.34 (-0.45, 1.14) 0.45 (-0.32, 1.23) 
≤20ng/ml  87 Ref Ref Ref Ref 
21 – 30ng/ml  93 -0.25 (-4.28, 4.79) 0.25 (-4.35, 4.86) 0.54 (-3.81, 4.89) 0.34 (-3.83, 4.53) 
> 30ng/ml  193 0.10 (-3.97, 4.18) -.025 (-4.54, 4.03) -0.14 (-4.19, 3.91) 0.14 (-3.75, 4.04) 
Diastolic 
Continuous 10 ng/ml 373 0.02 (-0.60, 0.64) 0.03 (-0.62, 0.69) 0.04 (-0.59, 0.67) 0.07 (-0.56, 0.71) 
≤20ng/ml  87 Ref Ref Ref Ref 
21 – 30ng/ml  93 -0.61 (-4.02, 2.79) -0.87 (-4.35, 2.60) -0.74 (-4.15, 2.66) -0.80 (-4.20, 2.59) 
> 30ng/ml  193 0.31 (-2.74, 3.38) 0.14 (-3.09, 3.38) 0.19 (-2.98, 3.37) 0.28 (-2.88, 3.45) 
Abbreviations: blood pressure systolic (Systolic), blood pressure diastolic (Diastolic).   
Model 1: Adjusted for sex and age of the child at the time of outcomes assessment.   
Model 2: Model 1 further adjusted for season, maternal education and physical activity of the children at 4 years.  
Model 3: Model 2 further adjusted for body mass index at 4 years.    
Model 4: Model 3 further adjusted for height at 11 years.    
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5. Discussion 
 
In this study of 373 mother-child pairs from the INMA-Sabadell cohort, we observed that maternal 
vitamin D levels during pregnancy were associated with an increase in systolic blood pressure at 
11 years, although the association was attenuated after considering the height of the child. No 
associations were observed between maternal vitamin D levels and offspring pulse wave velocity 
and retinal microcirculation at 11 years. Vitamin D levels in pre-school age were not associated 
with any of the cardiovascular measurements at 11 years.  
We did find a small association between concentrations of maternal vitamin D and pulse wave 
velocity in offspring. Our results are in agreement with the three studies completed prior. First 
study in Rotterdam, at Netherlands cohort study conducted examined whether 25‐hydroxyvitamin 
D (25(OH)D) concentrations during pregnancy and in cord blood were associated with childhood 
body composition and cardiovascular outcomes, however the authors found no association between 
concentrations of maternal vitamin D with pulse wave velocity in offspring49. The second study in 
Swedish, using the Swedish Phenylketonuria (PKU) Register, found no association between 
concentrations of neonatal vitamin D levels and pulse wave velocity in offspring at the age of 35 
years13. Last study in a prospective cohort study in south India, the authors used blood samples 
taken at 21 years and aortic pulse wave velocity at the same time as variables, there is no clear 
evidence between (25(OH)D3) and aortic pulse wave velocity50. Also this according to data found 
with adult population, as in the study conducted in adults in Korea, which were middle age (55 
years), they found an association between vitamin D and the measured variable of brachial pulse 
wave velocity51.  
We observed no association in preschool age children between (25(OH)D3) and pulse wave 
velocity, to the best of our knowledge, no published data have been found to date on this non-
association in preschool age.  
The retinal microcirculation is a new method to predict CVD in adults24 and children32. To the best 
of our knowledge, this is the first study exploring the association between vitamin D concentrations 
in mothers and during early childhood and retinal microcirculation in children at 11 years. Until 
the moment we find a publication that talks about assessed this association, in adults of ≥45 years 
of age and authors reported an association between low vitamin D levels (lower than 50nmol/L) 
and retinal micro vascular damage52.  
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A total of nine studies have explored the association between maternal vitamin D and blood 
pressure of the offspring13,14,49,53–58 , the majority of them found that higher levels of vitamin D 
decreased blood pressure. First study conducted in Denmark for example, found an inverse 
association between cord blood vitamin D levels with systolic blood pressure but only in girls53. 
Another study in North America found an association between vitamin D higher levels in cord 
blood and lower systolic and diastolic blood pressure in preschool age54. In Denmark, a cohort 
study found the same results, with no association between maternal (25(OH)D3) and diastolic 
blood pressure in offspring of 19–20 y14. The South West study found no association between 
maternal vitamin D and diastolic blood pressure at two different ages, at 9.9 and 15.4 years55. A 
North American study using cord blood samples, associated low levels (<11 ng/mL) of 
(25(OH)D3) in cord blood with an increase in the systolic blood pressure for a long time 3 to 18 
years56. In a Dutch study they used blood samples from the mother at second trimester and 
umbilical cord blood samples were collected at birth, although no association was found to diastolic 
blood pressure between (25(OH)D3)49. A study in obese children, in Italy, found that low levels of 
vitamin D were associated with high blood pressure57. A cross-sectional study in North American 
adults USA observed that high levels of vitamin D were associated with low systolic blood 
pressure58. Last study Sweden study in 275 subjects aged 35 years could not deliver an association 
between (25(OH)D3) to diastolic blood pressure13.  
However, in animal models, results have been somewhat contradictory. In a study using 
normotensive rats, high doses of cholecalciferol for two months (vitamin D supplementation), were 
associated with an increase of systolic blood pressure59. A study in male rats, found that vitamin D 
deficiency (mean plasma 25(OH)D level of 30 nmol/l) and toxicity (plasma 25(OH)D level of 
561nmol/l) induced an increase in systolic blood pressure60. In agreement with our results, none of 
them observed any association with diastolic blood pressure.  
The relationship between (25(OH)D3) at 4 years to systolic blood pressure was not found in this 
study, unlike others two studies in Korean61 and Peru62. The first study in Korean Study, using 
children of an average age of 13.74 y, using blood samples collected at the same age, they 
associated systolic and diastolic blood pressure between (25(OH)D3) and others metabolic 
syndrome, the study divided the concentrations of (25(OH)D3) into 4 quartiles, I (<13.10 ng/mL), 
II (≥13.10 to <16.63 ng/mL), III (≥16.63 to <20.86 ng/mL) and IV (≥20.86 ng/mL), in which they 
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found association that increased (25(OH)D3) reduced both blood pressures61. Second study in Peru, 
using adolescents, aged 13–15 years, they associated deficiency level (< 20 ng/ml) of (25(OH)D3) 
to increased systolic blood pressure (1.30 mm Hg increase, 95% confidence interval: −0.13 to 2.72; 
P = 0.08) and diastolic blood pressure (1.09 mm Hg increase, 95% confidence interval: 0.04 to 
2.14; P = 0.04)62.  
When we investigated the association between vitamin D at 4 years  and diastolic blood pressure, 
we didn't find association, in agreement with a cross-sectional population-based study with children 
aged 8 and 9 years in Brazil, children with 25(OH)D deficient levels (< 20 ng/ml) were not 
associated with diastolic blood pressure63, a case control examined association to vitamin A and 
vitamin D to cardiovascular risks in China, age between 6-12 y, they found a correlation between 
serum 25(OH)D levels and diastolic and systolic blood pressure, hypertensive children had lower 
vitamin D levels compared to a control64, but in obese child in Australia, middle age 12 years, there 
was found an association to lower levels (<50 nmol/L.) of serum (25(OH)D3) to high systolic and 
diastolic blood pressure65, the last study a clinical study in Iran, girls only, with supplementation 
to vitamin D, during 9 weeks, age between 12-18 y, they found association a significative reduction 
in diastolic blood pressure66.  
The main strengths of this study include the use of different novel non-invasive cardiovascular 
outcomes in childhood, the relatively large sample size, and the vitamin D measurements available 
at two times points. The main limitations include the loss of follow-up, and unknown familiar 
history of cardiovascular diseases. 
We found some small associations; that show a non-positive effect on developing children. We 
know of the importance of vitamin D levels during pregnancy and cardiovascular effects in 
offspring. Based on this, further research is needed to better understand vitamin D levels during 
pregnancy, the cardiovascular effects in offspring, and their casual mechanisms.  
 
6. Conclusion 
This study finds little evidence of associations of vitamin D levels during pregnancy and in pre-
school age with pulse wave velocity, retinal microcirculation and blood pressure in 11 age children. 
Further studies will be needed to understand more clearly the influence of prenatal vitamin D and 
early life on cardiovascular disease in childhood. 
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